Skip to main content
. 2017 Jun 9;10:29–34. doi: 10.1016/j.jgar.2017.03.009

Table 2.

Antimicrobial resistance of Shigella sonnei, 2006–2011.

Antimicrobial agent Resistant [% (n)]
2006 (N = 19) 2007 (N = 48) 2008 (N = 89) 2009 (N = 98) 2010 (N = 33) 2011 (N = 32) Overall (N = 319)
Ampicillin 52.6 (10) 81.3 (39) 48.3 (43) 77.6 (76) 60.6 (20) 87.5 (28) 67.7 (216)
AMC 52.6 (10) 97.9 (47) 39.3 (35) 30.6 (30) 0.0 (0) 18.8 (6) 40.1 (128)
Cefalotin 52.6 (10) 33.3 (16) 15.7 (14) 45.9 (45) 27.3 (9) 25.0 (8) 32.0 (102)
Cefotaxime 5.3 (1) 14.6 (7) 12.4 (11) 30.6 (30) 21.2 (7) 3.1 (1) 17.9 (57)
Gentamicin 26.3 (5) 8.3 (4) 39.3 (35) 34.7 (34) 33.3 (11) 78.1 (25) 35.7 (114)
Nalidixic acid 78.9 (15) 95.8 (46) 61.8 (55) 76.5 (75) 63.6 (21) 87.5 (28) 75.2 (240)
Norfloxacin 26.3 (5) 25.0 (12) 4.5 (4) 46.9 (46) 0.0 (0) 0.0 (0) 21.0 (67)
Tetracycline 73.7 (14) 93.8 (45) 58.4 (52) 73.5 (72) 72.7 (24) 87.5 (28) 73.7 (235)
SXT 68.4 (13) 72.9 (35) 64.0 (57) 65.3 (64) 81.8 (27) 71.9 (23) 68.7 (219)

AMC, amoxicillin/clavulanic acid; SXT, trimethoprim/sulfamethoxazole.